VOLT-02
Jump to navigation
Jump to search
Clinical data | |
---|---|
Other names | Progesterone conjugate |
Drug class | Progestogen; Neurosteroid |
Identifiers | |
CAS Number |
VOLT-02 is a water-soluble conjugate of progesterone and a neurosteroid which is under development by Levolta Pharmaceuticals (formerly Voltarra Pharmaceuticals) for the treatment of traumatic brain injury, gynecological disorders, and menstrual disorders.[1] As of March 2017, it is in phase II clinical trials for these indications.[1] The chemical structure of VOLT-02 does not appear to have been released yet.[1]
See also
- List of neurosteroids § Inhibitory > Synthetic > Pregnanes
- List of progestogen esters § Oximes of progesterone derivatives
- List of investigational sex-hormonal agents § Progestogenics
References
- ^ a b c "Progesterone conjugate - Levolta Pharmaceuticals - AdisInsight". adisinsight.springer.com.
External links
Categories:
- Articles with short description
- Short description matches Wikidata
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs with undisclosed chemical structures
- Experimental drugs
- Neuroprotective agents
- Neurosteroids
- Pregnanes
- Progestogens
- All stub articles
- Steroid stubs
- Nervous system drug stubs